Timpani Capital Management’s Core Laboratories CLB Stock Holding History

Timpani Capital Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$1.39M	Buy	+20,103	New	+$1.35M	0.66%	58

Other funds holding CLB

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Timpani Capital Management's CLB Position: Q1 2019 in Review

Timpani Capital Management opened a new position in Core Laboratories (CLB) in Q1 2019: 20,103 shares worth $1.39M. The stake represents 0.66% of the portfolio and ranks #58 among its holdings.

313 funds tracked by Wall St. Rank hold CLB as of Q1 2019.

Timpani Capital Management held 20,103 shares of Core Laboratories worth $1.39M as of Q1 2019.
Core Laboratories was a new Timpani Capital Management position in Q1 2019.
Core Laboratories made up 0.66% of Timpani Capital Management's portfolio in Q1 2019, its #58 holding.
313 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2019.

Based on Timpani Capital Management's 13F filing for Q1 2019, filed 10 May 2019.